Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
XENLETA (LEFAMULIN ACETATE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
XENLETA
NDA
Get alerts
LEFAMULIN ACETATE | N211673 | HONG KONG KING FRIEND INDUSTRIAL CO LTD
1 strength
3 unique patents
2 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Approvals
Label
Products
Patent Timeline
3 unique patents, 2 exclusivities by expiration date
Active (3)
Today
Exclusivity
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
Today
8071643
Mar. 25, 2033
8153689
Mar. 19, 2028
12121582
Jun. 14, 2036
NCE
Aug. 19, 2024
GAIN
Aug. 19, 2029
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 150MG BASE/15ML (EQ 10MG BASE/ML)
RLD
3 patents
2 exclusivities
▴
SOLUTION;INTRAVENOUS | Approved: Aug 19, 2019
Patents (3)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
8071643
Mar 25, 2033
—
Yes
Yes
—
—
8153689
Mar 19, 2028
—
Yes
Yes
—
—
12121582
Jun 14, 2036
—
—
Yes
—
—
Exclusivities (2)
Code
Date
Status
GAIN
Aug 19, 2029
Active
NCE
Aug 19, 2024
Expired